Urgent

Amiodarone-induced thyrotoxicosis

Drug-induced thyrotoxicosis · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Amiodarone can cause thyrotoxicosis by iodine load driving synthesis (type 1) or by a destructive thyroiditis (type 2), which respond to different treatments. It can be hard to distinguish and may precipitate arrhythmia or storm.

Figures & algorithms

Clinical features
Clinical features

Assessment

Investigations

  • TFTs; assess for arrhythmia/cardiac decompensation
  • Doppler thyroid (vascularity helps type 1 vs 2)
  • Review amiodarone and cardiac indication

Management

  • Beta-blockade for symptoms (caution in heart failure)
  • Type 1: anti-thyroid drugs (carbimazole) +/- potassium perchlorate
  • Type 2: corticosteroids (destructive thyroiditis)
  • Mixed/uncertain: often both; endocrine and cardiology input
  • Decide on stopping amiodarone with cardiology

Drugs & doses

Carbimazole (type 1)
Prednisolone (type 2)
Beta-blocker

Disposition

Endocrine + cardiology.

Amiodarone thyrotoxicosis is type 1 (give anti-thyroid drugs) or type 2 (give steroids) - and the two are easily confused, so involve endocrinology.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.